AB 1963: California State University and University of California: gene synthesis providers.
- Session Year: 2021-2022
- House: Assembly
- Latest Version Date: 2022-08-26
Existing law establishes the University of California, which is administered by the Regents of the University of California, and the California State University, which is administered by the Trustees of the California State University, as 2 of the segments of public postsecondary education in the state.
This bill would require the California State University, and request the University of California, to develop systemwide guidance for purchasing gene synthesis equipment or gene synthesis products from gene synthesis providers who prevent the misuse of synthetic genes and safeguard the benefits of gene synthesis technology while minimizing risk, and to consider including International Gene Synthesis Consortium (IGSC) criteria in their guidance.
Existing law establishes the University of California, which is administered by the Regents of the University of California, and the California State University, which is administered by the Trustees of the California State University, as 2 of the segments of public postsecondary education in the state.
This bill would require the California State University, and request the University of California, to develop systemwide guidance for purchasing gene synthesis equipment or gene synthesis products from gene synthesis providers who prevent the misuse of synthetic genes and safeguard the benefits of gene synthesis technology while minimizing risk, and to consider including International Gene Synthesis Consortium (IGSC) criteria in their guidance.
Existing law establishes the University of California, which is administered by the Regents of the University of California, and the California State University, which is administered by the Trustees of the California State University, as 2 of the segments of public postsecondary education in the state.
This bill would, beginning January 1, 2023, require any California State University campus, and request any University of California campus, to only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, that is a current member of the International Gene Synthesis Consortium (IGSC), as defined. The bill would require each campus of the California State University, and request each campus of the University of California, that purchases gene synthesis products or gene synthesis equipment to appoint the appropriate campus committee to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC. would require the California State University, and request the University of California, to develop systemwide guidance for purchasing gene synthesis equipment or gene synthesis products from gene synthesis providers who prevent the misuse of synthetic genes and safeguard the benefits of gene synthesis technology while minimizing risk, and to consider including International Gene Synthesis Consortium (IGSC) criteria in their guidance.
Existing law establishes the University of California, which is administered by the Regents of the University of California, and the California State University, which is administered by the Trustees of the California State University, as 2 of the segments of public postsecondary education in the state.
This bill would, beginning January 1, 2023, require any California State University campus, and request any University of California campus, to only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, that is a current member of the International Gene Synthesis Consortium (IGSC), as defined. The bill would require each campus of the California State University, and request each campus of the University of California, that purchases gene synthesis products or gene synthesis equipment to appoint a faculty member the appropriate campus committee to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC.
Existing law establishes the University of California, which is administered by the Regents of the University of California, and the California State University, which is administered by the Trustees of the California State University, as 2 of the segments of public postsecondary education in the state.
This bill would, beginning January 1, 2023, authorize require any California State University campus or campus, and request any University of California campus campus, to choose to only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, that is a current member of the International Gene Synthesis Consortium (IGSC), as defined. The bill would authorize require each campus of the California State University or University, and request each campus of the University of California California, that purchases gene synthesis products or gene synthesis equipment to appoint a faculty member to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC.
Existing law establishes the University of California, which is administered by the Regents of the University of California, and the California State University, which is administered by the Trustees of the California State University, as 2 of the segments of public postsecondary education in the state.
This bill would, beginning January 1, 2023, require authorize any California State University campus or University of California campus to choose to only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, only if they are that is a current member of the International Gene Synthesis Consortium (IGSC), as defined. The bill would require authorize each campus of the California State University or the University of California that purchases gene synthesis products or gene synthesis equipment to appoint a faculty member to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC.
Existing law establishes the University of California, which is administered by the Regents of the University of California, and the California State University, which is administered by the Trustees of the California State University, as 2 of the segments of public postsecondary education in the state.
This bill would, beginning January 1, 2023, require any California State University campus or University of California campus to purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, only if they are a current member of the International Gene Synthesis Consortium (IGSC), as defined. The bill would require each campus of the California State University or the University of California that purchases gene synthesis products or gene synthesis equipment to appoint a faculty member to ensure that gene synthesis products and gene synthesis equipment is purchased from a current member of the IGSC.
For the purposes of this chapter, the following terms apply:
(a)Gene synthesis equipment means equipment needed to produce gene synthesis products that is not readily used for any other purpose.
(b)Gene synthesis product is double-stranded DNA (dsDNA), double-stranded nucleic acids, RNA, or oligonucleotides, designed and created without an existing DNA template.
(c)(1)Gene synthesis provider means an entity that does any of the following:
(A)An entity that creates gene synthesis products for delivery to a customer.
(B)A distributor of gene synthesis products, including, but not limited to, entities who manufacture gene synthesis products for use by other parties, both inside and outside of the entity.
(C)A third-party entity that is not the end user of a gene synthesis product and does not make gene synthesis products, but otherwise fills, completes, modifies, or purifies gene synthesis products.
(2)Gene synthesis provider does not include a research scientist making gene synthesis products for the research scientists own use or for use by another research scientist or an entity that manufactures gene synthesis products for the entitys own use.
66361.(a)The California State University shall, and the University of California is requested to, develop systemwide guidance for purchasing gene synthesis equipment or gene synthesis products from gene synthesis providers who prevent the misuse of synthetic genes and safeguard the benefits of gene synthesis technology while minimizing risk.
(b)The California State University shall, and the University of California is requested to, consider including International Gene Synthesis Consortium (IGSC) criteria in their guidance.
For the purposes of this chapter, the following terms apply:
(a)Gene synthesis equipment means equipment needed to produce gene synthesis products that is not readily used for any other purpose.
(b)Gene synthesis product is double-stranded DNA (dsDNA), double-stranded nucleic acids, RNA, or oligonucleotides, designed and created without an existing DNA template.
(c)(1)Gene synthesis provider means an entity that does any of the following:
(A)An entity that creates gene synthesis products for delivery to a customer.
(B)A distributor of gene synthesis products, including, but not limited to, entities who manufacture gene synthesis products for use by other parties, both inside and outside of the entity.
(C)A third-party entity that is not the end user of a gene synthesis product and does not make gene synthesis products, but otherwise fills, completes, modifies, or purifies gene synthesis products.
(2)Gene synthesis provider does not include a research scientist making gene synthesis products for the research scientists own use or for use by another research scientist or an entity that manufactures gene synthesis products for the entitys own use.
66361.(a)The California State University shall, and the University of California is requested to, develop systemwide guidance for purchasing gene synthesis equipment or gene synthesis products from gene synthesis providers who prevent the misuse of synthetic genes and safeguard the benefits of gene synthesis technology while minimizing risk.
(b)The California State University shall, and the University of California is requested to, consider including International Gene Synthesis Consortium (IGSC) criteria in their guidance.
For the purposes of this chapter, the following terms apply:
(a)Current member means a current member of the International Gene Synthesis Consortium (IGSC) who is a certified member of that organization and includes voting members, small company members, and nonprofit members. It does not include provisional associate members or any other membership tier where the entity does not implement an IGSC tested and approved screening system.(b)(a)Gene synthesis equipment means equipment needed to produce gene synthesis products that is not readily used for any other purpose.
(c)(b)Gene synthesis product is double-stranded DNA (dsDNA), double-stranded nucleic acids, RNA, or oligonucleotides, designed and created without an existing DNA template.
(d)(c)(1)Gene synthesis provider means an entity that does any of the following:
(A)An entity that creates gene synthesis products for delivery to a customer.
(B)A distributor of gene synthesis products, including, but not limited to, entities who manufacture gene synthesis products for use by other parties, both inside and outside of the entity.
(C)A third-party entity that is not the end user of a gene synthesis product and does not make gene synthesis products, but otherwise fills, completes, modifies, or purifies gene synthesis products.
(2)Gene synthesis provider does not include a research scientist making gene synthesis products for the research scientists own use or for use by another research scientist or an entity that manufactures gene synthesis products for the entitys own use.
66361.(a)Beginning January 1, 2023, any California State University campus shall, and any University of California campus is requested to, only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, that is a current member of the IGSC, as defined.(b)Each campus of the California State University that purchases gene synthesis products or gene synthesis equipment shall appoint the appropriate campus committee to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC, as defined. Each campus of the University of California that purchases gene synthesis products or gene synthesis equipment is requested to appoint the appropriate campus committee to ensure that gene synthesis products and gene synthesis equipment is purchased from a current member of the IGSC, as defined.66361.(a)The California State University shall, and the University of California is requested to, develop systemwide guidance for purchasing gene synthesis equipment or gene synthesis products from gene synthesis providers who prevent the misuse of synthetic genes and safeguard the benefits of gene synthesis technology while minimizing risk.
(b)The California State University shall, and the University of California is requested to, consider including International Gene Synthesis Consortium (IGSC) criteria in their guidance.
For the purposes of this chapter, the following terms apply:
(a)Current member means a current member of the International Gene Synthesis Consortium (IGSC) who is a certified member of that organization and includes voting members, small company members, and nonprofit members. It does not include provisional associate members or any other membership tier where the entity does not implement an IGSC tested and approved screening system.
(b)Gene synthesis equipment means equipment needed to produce gene synthesis products that is not readily used for any other purpose.
(c)Gene synthesis product is double-stranded DNA (dsDNA), double-stranded nucleic acids, RNA, or oligonucleotides, designed and created without an existing DNA template.
(d)(1)Gene synthesis provider means an entity that does any of the following:
(A)An entity that creates gene synthesis products for delivery to a customer.
(B)A distributor of gene synthesis products, including, but not limited to, entities who manufacture gene synthesis products for use by other parties, both inside and outside of the entity.
(C)A third-party entity that is not the end user of a gene synthesis product and does not make gene synthesis products, but otherwise fills, completes, modifies, or purifies gene synthesis products.
(2)Gene synthesis provider does not include a research scientist making gene synthesis products for the research scientists own use or for use by another research scientist or an entity that manufactures gene synthesis products for the entitys own use.
66361.(a)Beginning January 1, 2023, any California State University campus shall, and any University of California campus is requested to, only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, that is a current member of the IGSC, as defined.
(b)Each campus of the California State University that purchases gene synthesis products or gene synthesis equipment shall appoint a faculty member the appropriate campus committee to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC, as defined. Each campus of the University of California that purchases gene synthesis products or gene synthesis equipment is requested to appoint a faculty member the appropriate campus committee to ensure that gene synthesis products and gene synthesis equipment is purchased from a current member of the IGSC, as defined.
For the purposes of this chapter, the following terms apply:
(a)Current member means a current member of the International Gene Synthesis Consortium (IGSC) who is a certified member of that organization and includes voting members, small company members, and nonprofit members. It does not include provisional associate members or any other membership tier where the entity does not implement an IGSC tested and approved screening system.
(b)Gene synthesis equipment means equipment needed to produce gene synthesis products that is not readily used for any other purpose.
(c)Gene synthesis product is double-stranded DNA (dsDNA), double-stranded nucleic acids, RNA, or oligonucleotides, designed and created without an existing DNA template.
(d)(1)Gene synthesis provider means an entity that does any of the following:
(A)An entity that creates gene synthesis products for delivery to a customer.
(B)A distributor of gene synthesis products, including, but not limited to, entities who manufacture gene synthesis products for use by other parties, both inside and outside of the entity.
(C)A third-party entity that is not the end user of a gene synthesis product and does not make gene synthesis products, but otherwise fills, completes, modifies, or purifies gene synthesis products.
(2)Gene synthesis provider does not include a research scientist making gene synthesis products for the research scientists own use or for use by another research scientist or an entity that manufactures gene synthesis products for the entitys own use.
66361.(a)Beginning January 1, 2023, any California State University campus or shall, and any University of California campus may choose to is requested to, only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, that is a current member of the IGSC, as defined.
(b)Each campus of the California State University or the University of California that purchases gene synthesis products or gene synthesis equipment may shall appoint a faculty member to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC, as defined. Each campus of the University of California that purchases gene synthesis products or gene synthesis equipment is requested to appoint a faculty member to ensure that gene synthesis products and gene synthesis equipment is purchased from a current member of the IGSC, as defined.
For the purposes of this chapter, the following terms apply:
(a)Current member means a current member of the International Gene Synthesis Consortium (IGSC) who is a certified member of that organization and includes voting members, small company members, and nonprofit members. It does not include provisional associate members or any other membership tier where the entity does not implement an IGSC tested and approved screening system.
(b)Gene synthesis equipment means equipment needed to produce gene synthesis products that is not readily used for any other purpose.
(c)Gene synthesis product is double-stranded DNA (dsDNA), double-stranded nucleic acids, RNA, or oligonucleotides, designed and created without an existing DNA template.
(d)(1)Gene synthesis provider means an entity that does any of the following:
(A)An entity that creates gene synthesis products for delivery to a customer.
(B)A distributor of gene synthesis products, including, but not limited to, entities who manufacture gene synthesis products for use by other parties, both inside and outside of the entity.
(C)A third-party entity that is not the end user of a gene synthesis product and does not make gene synthesis products, but otherwise fills, completes, modifies, or purifies gene synthesis products.
(2)Gene synthesis provider does not include a research scientist making gene synthesis products for the research scientists own use or for use by another research scientist or an entity that manufactures gene synthesis products for the entitys own use.
66361.(a)Beginning January 1, 2023, any California State University campus or University of California campus shall may choose to only purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, only if they are that is a current member of the IGSC, as defined.
(b)An entity that does not comply with subdivision (a) may have access to all state resources revoked for the duration of the noncompliance.(c)(b)Each campus of the California State University or the University of California that purchases gene synthesis products or gene synthesis equipment shall may appoint a faculty member to ensure that gene synthesis products and gene synthesis equipment is only purchased from a current member of the IGSC, as defined.
For the purposes of this chapter, the following terms apply:
(a)Current member means a current member of the International Gene Synthesis Consortium (IGSC) who is a certified member of that organization and includes voting members, small company members, and nonprofit members. It does not include provisional associate members or any other membership tier where the entity does not implement an IGSC tested and approved screening system.
(b)Gene synthesis equipment means equipment needed to produce gene synthesis products that is not readily used for any other purpose.
(c)Gene synthesis product is double-stranded DNA (dsDNA), double-stranded nucleic acids, RNA, or oligonucleotides, designed and created without an existing DNA template.
(d)(1)Gene synthesis provider means an entity that does any of the following:
(A)An entity that creates gene synthesis products for delivery to a customer.
(B)A distributor of gene synthesis products, including, but not limited to, entities who manufacture gene products for use by other parties, both inside and outside of the entity.
(C)A third-party entity that is not the end user of a gene synthesis product and does not make gene synthesis products, but otherwise fills, completes, modifies, or purifies gene synthesis products.
(2)Gene synthesis provider does not include a research scientist making gene synthesis products for the research scientists own use or for use by another research scientist or an entity that manufactures gene synthesis products for the entitys own use.
66361.(a)Beginning January 1, 2023, any California State University campus or University of California campus shall purchase gene synthesis products from a gene synthesis provider, and gene synthesis equipment from a manufacturer of gene synthesis equipment, only if they are a current member of the IGSC, as defined.
(b)An entity that does not comply with subdivision (a) may have access to all state resources revoked for the duration of the noncompliance.
(c)Each campus of the California State University or the University of California that purchases gene synthesis products or gene synthesis equipment shall appoint a faculty member to ensure that gene synthesis products and gene synthesis equipment is purchased from a current member of the IGSC, as defined.
|
Date
|
Status
|
|---|---|
| Aug 26, 2022 | Chaptered by Secretary of State - Chapter 179, Statutes of 2022. |
| Aug 26, 2022 | Approved by the Governor. |
| Aug 16, 2022 | Enrolled and presented to the Governor at 4 p.m. |
| Aug 11, 2022 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 72. Noes 0. Page 5812.). |
| Aug 8, 2022 | In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 10 pursuant to Assembly Rule 77. |
| Aug 8, 2022 | Read third time. Passed. Ordered to the Assembly. (Ayes 36. Noes 0. Page 4680.). |
| Aug 2, 2022 | Read second time. Ordered to Consent Calendar. |
| Aug 1, 2022 | From committee: Be ordered to second reading file pursuant to Senate Rule 28.8 and ordered to Consent Calendar. |
| Jun 30, 2022 | From committee: Do pass and re-refer to Com. on APPR with recommendation: To Consent Calendar. (Ayes 10. Noes 0.) (June 29). Re-referred to Com. on APPR. |
| Jun 14, 2022 | Read second time and amended. Re-referred to Com. on HEALTH. |
| Jun 13, 2022 | From committee: Amend, and do pass as amended and re-refer to Com. on HEALTH. (Ayes 7. Noes 0.) (June 8). |
| May 18, 2022 | Referred to Coms. on ED. and HEALTH. |
| May 5, 2022 | In Senate. Read first time. To Com. on RLS. for assignment. |
| May 5, 2022 | Read third time. Passed. Ordered to the Senate. (Ayes 51. Noes 0. Page 4572.) |
| Apr 28, 2022 | Read second time. Ordered to third reading. |
| Apr 27, 2022 | From committee: Do pass. (Ayes 11. Noes 0.) (April 27). |
| Apr 6, 2022 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (April 5). Re-referred to Com. on APPR. |
| Mar 29, 2022 | Re-referred to Com. on HIGHER ED. |
| Mar 28, 2022 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HIGHER ED. Read second time and amended. |
| Mar 15, 2022 | Re-referred to Com. on HIGHER ED. |
| Mar 14, 2022 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HIGHER ED. Read second time and amended. |
| Mar 8, 2022 | Re-referred to Com. on HIGHER ED. |
| Mar 7, 2022 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HIGHER ED. Read second time and amended. |
| Feb 18, 2022 | Referred to Com. on HIGHER ED. |
| Feb 11, 2022 | From printer. May be heard in committee March 13. |
| Feb 10, 2022 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 11, 2022 | AB 1963 Salas Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Aug 8, 2022 | Consent Calendar AB1963 | Senate Floor |
Passed |
|
| May 5, 2022 | AB 1963 Salas Assembly Third Reading | Assembly Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Bill Author
Bill Co-Author(s):